He Xiangmin, Jiang Li, Fu Baoyu, Zhang Xue
Department of Gastroenterology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China.
Zhonghua Yi Xue Za Zhi. 2002 May 25;82(10):685-8.
To investigate the polymorphisms of interleukin-1B (IL-1B) promotor region 31 C/T and interleukin-1 receptor antagonist (IL-1RN) gene and the relationship between the genotype of IL-1 and IL-1RN and susceptibility to gastric cancer in Chinese population.
Genomic DNA was extracted from the juxta-cancerous normal mucosal biopsies of 50 patients with gastric cancer taken by endoscopy and from the peripheral lymphocytes of 50 normal controls and then was subjected to PCR amplification. The PCR product was digested by restriction endonuclease Alu I. The product of digestion was subjected to 2% agarose gel electrophoresis and ethidium bromide staining.
The IL-1B -31C allele was detected in 75% of normal controls and 53% of patients, while the IL-1B -31T allele was detected in 25% of normal controls and 47% of patients. The frequency of -31C/-31C was 56% (28/56) and 30% (15/50) in normal controls and patients respectively. The frequency of -31C/-31T was 38% (19/56) and 46% (23/50) in normal controls and patients respectively. The frequency of -31T/-31T was 6% (3/56) and 24% (12/50) in normal controls and patients respectively. IL-1B -31T carriers were at increased risk of gastric cancer with an odds ratio of 7.5 for -31T/-31T homozygotes (95% CI, 2.0 approximately 27.6) and of 2.3 for -31C/-31T (95% CI, 0.9 approximately 5.4) respectively. Only three of the five kinds of polymorphism of IL-1RN (1/1, 1/2 and 2/2) were found in this study. The frequency of 1/1 was 54% (27/50) and 24% (12/50) in normal controls and patients respectively. The frequency of 1/2 was 38% (19/50) and 50% (25/50) in normal controls and patients respectively. The frequency of 2/2 was 8% (4/50) and 26% (13/50) in normal controls and patients respectively. The IL-1RN * 1 allele was detected in 73% of normal controls and 49% of patients; while the IL-1RN * 2 allele was detected in 27% of normal controls and 51% of patients. IL-RN * 2 carriers were at increased risk of gastric cancer with an odds ratio of 7.31 for 2/2 homozygotes (95% CI 2.13 approximately 25.09) and of 2.96for 1/2 heterozygotes (95% CI 1.22 approximately 7.21), respectively.
The polymorphism of promotor region -31C/T of IL-1B gene and the polymorphism of IL-1RN genes 1/2 and 2/2 are associated with the susceptibility of gastric cancer in Chinese. Carrying -31T allele increases the risk of gastric cancer. Polymorphism of IL-1RN and IL-1B gene may be used as indicators of susceptibility of gastric carcinogenesis.
研究白细胞介素-1β(IL-1β)启动子区域31C/T多态性和白细胞介素-1受体拮抗剂(IL-1RN)基因多态性,以及IL-1与IL-1RN基因分型与中国人群胃癌易感性的关系。
采用内镜取材,获取50例胃癌患者癌旁正常黏膜活检组织,同时取50例正常对照者外周血淋巴细胞,提取基因组DNA,进行PCR扩增。PCR产物用限制性内切酶Alu I酶切,酶切产物进行2%琼脂糖凝胶电泳及溴化乙锭染色。
正常对照者中75%检测到IL-1β -31C等位基因,患者中53%检测到该等位基因;正常对照者中25%检测到IL-1β -31T等位基因,患者中47%检测到该等位基因。-31C/-31C基因型在正常对照者和患者中的频率分别为56%(28/50)和30%(15/50)。-31C/-31T基因型在正常对照者和患者中的频率分别为38%(19/50)和46%(23/50)。-31T/-31T基因型在正常对照者和患者中的频率分别为6%(3/50)和24%(12/50)。IL-1β -31T携带者患胃癌风险增加,-31T/-31T纯合子的比值比为7.5(95%可信区间,2.0至27.6),-31C/-31T杂合子的比值比为2.3(95%可信区间,0.9至5.4)。本研究仅发现IL-1RN五种多态性中的三种(1/1、1/2和2/2)。1/1基因型在正常对照者和患者中的频率分别为54%(27/50)和24%(12/50)。1/2基因型在正常对照者和患者中的频率分别为38%(19/50)和50%(25/50)。2/2基因型在正常对照者和患者中的频率分别为8%(4/50)和26%(13/50)。正常对照者中73%检测到IL-1RN * 1等位基因,患者中49%检测到该等位基因;正常对照者中27%检测到IL-1RN * 2等位基因,患者中51%检测到该等位基因。IL-RN * 2携带者患胃癌风险增加,2/2纯合子的比值比为7.31(95%可信区间2.13至25.09),1/2杂合子的比值比为2.96(95%可信区间1.22至7.21)。
IL-1β基因启动子区域-31C/T多态性以及IL-1RN基因1/2和2/2多态性与中国人群胃癌易感性相关。携带-31T等位基因会增加患胃癌的风险。IL-1RN和IL-1β基因多态性可能作为胃癌发生易感性的指标。